US2007009921A1PendingUtilityA1
Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances
Est. expiryApr 10, 2019(expired)· nominal 20-yr term from priority
A61P 43/00A61P 31/18C12N 2710/22022C07K 14/005A61K 47/6901C07K 14/645A61K 38/00A61K 47/62A61K 2039/5258C07K 14/025Y02A50/30
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a synthetic, biologically active molecule for fixing an active ingredient to the virus protein 1 (VP1) of the polyoma virus. According to the invention, an amino acid sequence A1 which is derived from the C-terminal end of virus protein 2 (VP2) or 3 (VP3) of the polyoma virus is bonded to an active ingredient at one of its ends.
Claims
exact text as granted — not AI-modified1 . A synthetic biologically active molecule composed of an active substance and an amino acid sequence (A1) derived from the C-terminal end of virus protein 2 (VP2) or 3 (VP3) of polyoma virus, wherein the active substance is bound to the amino acid sequence (A1) so that the active substance can be associated with the virus protein 1 (VP1) of polyoma virus by means of the amino acid sequence (A1) with the formation of a structured capsomer, and wherein the amino acid sequence (A1) linked to the active substance is not VP2 or VP3.
Join the waitlist — get patent alerts
Track US2007009921A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.